Stayble Therapeutics Valuation
| STABL Stock | SEK 0.57 0.02 3.64% |
Stayble Therapeutics is overvalued. Stayble Therapeutics has a current Real Value of kr0.53 per share. The regular price of the company is kr0.57. Our model measures the value of Stayble Therapeutics from inspecting the company fundamentals such as Return On Equity of -0.76, shares owned by insiders of 32.55 %, and Current Valuation of 15.2 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Stayble Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Stayble Therapeutics is based on 3 months time horizon. Increasing Stayble Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Stayble stock is determined by what a typical buyer is willing to pay for full or partial control of Stayble Therapeutics AB. Since Stayble Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Stayble Stock. However, Stayble Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.57 | Real 0.53 | Hype 0.57 | Naive 0.51 |
The intrinsic value of Stayble Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Stayble Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Stayble Therapeutics AB helps investors to forecast how Stayble stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Stayble Therapeutics more accurately as focusing exclusively on Stayble Therapeutics' fundamentals will not take into account other important factors: Stayble Therapeutics Total Value Analysis
Stayble Therapeutics AB is at this time projected to have takeover price of 15.2 M with market capitalization of 49.02 M, debt of 850 K, and cash on hands of 42.71 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Stayble Therapeutics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.2 M | 49.02 M | 850 K | 42.71 M |
Stayble Therapeutics Asset Utilization
One of the ways to look at asset utilization of Stayble is to check how much profit was generated for every dollar of assets it reports. Stayble Therapeutics has a negative utilization of assets of -0.44 %, losing kr0.004406 for each kronor of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each kronor of assets it has. In other words, asset utilization of Stayble Therapeutics AB shows how discouraging it operates for each kronor spent on its assets.Stayble Therapeutics Ownership Allocation
The market capitalization of Stayble Therapeutics is kr49.02 Million. Stayble Therapeutics maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Stayble Therapeutics Profitability Analysis
Net Loss for the year was (12.09 M) with profit before overhead, payroll, taxes, and interest of 9 K.About Stayble Therapeutics Valuation
The stock valuation mechanism determines Stayble Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Stayble Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Stayble Therapeutics. We calculate exposure to Stayble Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Stayble Therapeutics's related companies.Stayble Therapeutics AB develops injectable treatment for chronic low back pain triggered by disc degeneration. Stayble Therapeutics AB is based in Gothenburg, Sweden. Stayble Therapeutics is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Stayble Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Stayble Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Stayble Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Stayble Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Stayble Therapeutics' revenue streams: Identify Stayble Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Stayble Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Stayble Therapeutics' growth potential: Evaluate Stayble Therapeutics' management, business model, and growth potential.
- Determine Stayble Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Stayble Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Stayble Stock Analysis
When running Stayble Therapeutics' price analysis, check to measure Stayble Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stayble Therapeutics is operating at the current time. Most of Stayble Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stayble Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stayble Therapeutics' price. Additionally, you may evaluate how the addition of Stayble Therapeutics to your portfolios can decrease your overall portfolio volatility.